Endymed Ltd (ENDY.TA)
ILA 282.7
(-2.75%)
ILA 282.7
(-2.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 922 Thousand USD | -32.55% |
| 2022 | 1.36 Million USD | -54.69% |
| 2021 | 3.01 Million USD | 484.69% |
| 2020 | 516 Thousand USD | -72.68% |
| 2019 | 1.88 Million USD | -12.18% |
| 2018 | 2.15 Million ILS | 179.14% |
| 2017 | -2.71 Million ILS | 9.94% |
| 2016 | -3.01 Million ILS | 5.57% |
| 2015 | -3.19 Million USD | -113.21% |
| 2014 | -1.49 Million USD | -461.42% |
| 2013 | -267 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -100 Thousand USD | 85.07% |
| 2024 Q1 | -670 Thousand USD | -653.72% |
| 2023 Q2 | 226 Thousand USD | -77.47% |
| 2023 Q1 | 1 Million USD | 152.01% |
| 2023 Q4 | 121 Thousand USD | 128.27% |
| 2023 Q3 | -428 Thousand USD | -289.38% |
| 2023 FY | 922 Thousand USD | -32.55% |
| 2022 Q3 | -174 Thousand USD | -172.2% |
| 2022 FY | 1.36 Million USD | -54.69% |
| 2022 Q4 | 398 Thousand USD | 328.74% |
| 2022 Q2 | 241 Thousand USD | -73.28% |
| 2022 Q1 | 902 Thousand USD | 290.48% |
| 2021 Q4 | 231 Thousand USD | -71.52% |
| 2021 Q1 | 785 Thousand USD | 1153.69% |
| 2021 Q2 | 1.19 Million USD | 51.59% |
| 2021 FY | 3.01 Million USD | 484.69% |
| 2021 Q3 | 811 Thousand USD | -31.85% |
| 2020 Q3 | -74.5 Thousand USD | -128.82% |
| 2020 Q1 | 258.5 Thousand USD | -58.1% |
| 2020 Q2 | 258.5 Thousand USD | 0.0% |
| 2020 Q4 | -74.5 Thousand USD | 0.0% |
| 2020 FY | 516 Thousand USD | -72.68% |
| 2019 Q2 | 772 Thousand ILS | 291.88% |
| 2019 Q3 | 303 Thousand ILS | -60.75% |
| 2019 FY | 1.88 Million USD | -12.18% |
| 2019 Q4 | 617 Thousand USD | 103.63% |
| 2019 Q1 | 197 Thousand ILS | -73.23% |
| 2018 Q1 | 470 Thousand ILS | 135.63% |
| 2018 FY | 2.15 Million ILS | 179.14% |
| 2018 Q4 | 736 Thousand ILS | 89.69% |
| 2018 Q3 | 388 Thousand ILS | -30.34% |
| 2018 Q2 | 557 Thousand ILS | 18.51% |
| 2017 Q2 | -251 Thousand USD | 66.35% |
| 2017 Q3 | -402 Thousand USD | -60.16% |
| 2017 Q4 | -1.31 Million USD | -228.11% |
| 2017 FY | -2.71 Million ILS | 9.94% |
| 2017 Q1 | -746 Thousand USD | 16.74% |
| 2016 Q2 | -880 Thousand USD | 25.55% |
| 2016 Q3 | 20 Thousand USD | 102.27% |
| 2016 FY | -3.01 Million ILS | 5.57% |
| 2016 Q4 | -896 Thousand USD | -4580.0% |
| 2016 Q1 | -1.18 Million USD | 11.46% |
| 2015 FY | -3.19 Million USD | -113.21% |
| 2015 Q4 | -1.33 Million USD | -52.05% |
| 2015 Q3 | -878 Thousand USD | -172.67% |
| 2015 Q2 | -322 Thousand USD | 51.29% |
| 2015 Q1 | -661 Thousand USD | -27.12% |
| 2014 Q2 | -285 Thousand USD | -12.2% |
| 2014 Q1 | -254 Thousand USD | -0.2% |
| 2014 FY | -1.49 Million USD | -461.42% |
| 2014 Q4 | -520 Thousand USD | -107.17% |
| 2014 Q3 | -251 Thousand USD | 11.93% |
| 2013 FY | -267 Thousand USD | 0.0% |
| 2013 Q2 | -74.53 Thousand USD | 47.64% |
| 2013 Q3 | 198.49 Thousand USD | 366.32% |
| 2013 Q4 | -253.48 Thousand USD | -227.7% |
| 2013 Q1 | -142.33 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|